One page, thousands of outlets. See who else covered it.
A proposed package would let privacy pools pay their own transaction fees without relying on intermediaries.
We haven't written up this one. Decrypt has the full story — the link below goes straight to it.
(MedPage Today) -- Not many allergists are mourning the exit of the first and only FDA-approved oral immunotherapy (OIT) product -- peanut allergy treatment Palforzia -- from the market.
Key PointsThe State Street SPDR S&P Pharmaceuticals ETF offers a significantly lower expense ratio of 0.35% compared to the Invesco Pharmaceuticals ETF.
Silver (XAG/USD) price surges nearly 1.80% on Monday as the Greenback dives, while uncertainty over the US-Iran conflict clouds investor sentiment.
Heading for higher yields.
Andreessen Horowitz has closely aligned itself with the second Trump administration.